Aerospace and Mechanical Insider on MSN

Engineering job ads reveal key skills and pay trends

An extensive analysis of 26,103 engineering job advertisements offers a detailed view of the technical and professional ...
Bumblebees faced with a challenge know how to play ball. Buff-tailed bumblebees can figure out on their own how to use a ball as a ladder to nab sugar from an out-of-reach fake flower, researchers ...
German psychologist Wolfgang Köhler set up a famous experiment more than 100 years ago that changed how scientists understand animal intelligence and the power of insight — or spontaneous ...
In a new study, bumble bees solve a completely novel object-manipulation task. What makes this behavior especially remarkable is that the bees had never been trained. The findings challenge the ...
OpenAI's AI model solved the unit distance problem posed by Paul Erdos in 1946 The AI found a counterexample disproving Erdos's conjecture on unit-distance pairs The solution shows unit-distance pairs ...
Leaders often fall into the ‘fixer trap,’ solving problems instead of developing their teams. This piece shows how stepping back builds independent thinkers, strengthens trust and scales leadership ...
Some readers may solve the problem procedurally: line up the two numbers, add the ones column, carry the one, and add the tens to get 43. Others might instead notice a creative shortcut: 29 + 14 is ...
Amateur mathematicians are using artificial intelligence chatbots to solve long-standing problems, in a move that has taken professionals by surprise. While the problems in question aren’t the most ...
Solve Intelligence, the AI platform for the $200B+ patent industry, has raised $40M in Series B funding and is launching a new product for generating patent claim charts. Solve’s Series B comes just ...
Solve Therapeutics will use an oversubscribed round to advance two clinical antibody-drug conjugates and build out its proprietary linker platform. (iStock/Getty Images Plus) A San Diego biotech has ...
SAN DIEGO--(BUSINESS WIRE)--Solve Therapeutics, a clinical-stage biotechnology company developing best-in-class antibody-drug conjugates (ADCs) for solid tumor malignancies, today announced it has ...